Circadian genes control the daily changes of the circadian rhythms in a variety of physiological processes, which in turn regulate many functions in the human body. Disruption of circadian rhythms can have a profound influence on our well-being. We established a set of PCR primers and fluorescent probes to analyze the mRNA levels of nine different circadian genes, and used immunohistochemical methods to study four important circadian proteins in 35 endometrial cancers and their paired non-cancerous tissues. Of these, 13 cases showed reduced expression in all nine circadian genes in the cancerous tissues relative to the paired non-cancerous tissues; the remaining cases showed similar reduced expression in 4-8 of the genes analyzed. Conversely, 3 non-cancerous tissues showed reduced expression in all nine circadian genes in comparison with their respective adjacent cancerous tissues, whereas 6 other non-cancerous tissues showed reduced expression in 6-8 of the circadian genes. These results were also confirmed by immunohistochemical study. Expression of the circadian genes is perturbed in endometrial cancer. Based on these results, we suggest that different circadian rhythms occur in endometrial cancer and non-cancerous tissues. Our results may provide the molecular basis for chronotherapy of endometrial cancer.
Introduction
Most organisms exhibit daily changes in a variety of physiological and molecular processes such as gene expression, metabolism, and behavior (1) (2) (3) (4) (5) (6) . Many of the daily changes are controlled by autonomous biological pacemakers called circadian clocks. These clocks provide an organism with survival advantages by organizing its behavior and physiology around cyclic changes in the environment. The mammalian circadian clock comprises three parts: input pathways, central pacemaker and output pathways. The input pathways transmit messages from the environment to the central pacemaker, which synchronizes rhythm with environment to generate endogenous rhythms. Subsequently, the output pathways convert instructions from the central pacemaker into daily oscillations in various physiological and behavioral processes (3, 7) . In mammals, the central pacemaker is located in the suprachiasmatic nucleus (SCN) of the anterior hypothalamus. At present, nine circadian genes have been identified: Period 1-3 (PER1-3), Cryptochrome 1 and 2 (CRY1 and CRY2), CLOCK, BMAL1, TIM, and casein kinase 1Â (CK1Â) (1) (2) (3) (4) (5) (6) (7) (8) . The levels of mRNA and protein of each of these genes oscillate robustly during the 24-h circadian cycle with the exception of those of CLOCK and CK1Â.
Circadian rhythms are generated by the feedback loops of core circadian genes (1) (2) (3) (4) (5) (6) (7) . In the SCN neurons, intracellular levels of the CLOCK protein remain steady throughout the 24-h period, whereas the BMAL1 protein levels are high at the beginning of a subjective day and low at the beginning of a subjective night. The high level of BMAL1 promotes the formation of a BMAL1-CLOCK heterodimer that binds to E-box sequences in the promoters, leading to activation of the CRY, PER and REV-ERB· genes. The newly synthesized proteins then enter the nucleus to shut down transcription of the BMAL1 and CRY genes. In the case of the PER protein family, the PER1 and other PER family proteins accumulate in the cytoplasm, where they become phosphorylated by CK1Â. The phosphorylated forms of PER are unstable and are degraded by ubiquitylation. Late in the subjective day, however, CRY accumulates in the cytoplasm promoting the formation of stable CK1Â/PER/CRY complexes, which enter the nucleus at the beginning of a subjective night. Once in the nucleus, CRY1 disrupts the CLOCK/BMAL1-associated transcriptional complex resulting in inhibition of the transcription of CRY, PER, REV-ERB· genes and derepression of BMAL1 transcription (3,7,9). The interacting positive and negative feedback loops of the circadian genes ensure low levels of PER and CRY and a high level of BMAL1 at the beginning of a new circadian day (1, 3, 7, 9) . The core oscillatory mechanism seems to be common to both the SCN and peripheral clocks distributed in most tissues and cells (10, 11) . However, peripheral clocks are different from the central clock in that the circadian expression of the clock genes persists only for several days in culture (10) . Expression of the cyclic genes in peripheral clocks is probably sustained by synchronization with some neural and/or humoral signals generated by SCN in a circadian manner (3, 10) .
Circadian rhythms regulate many functions in the human body including sleep and wakefulness, body temperature, blood pressure, hormone production, digestive secretion and immune activity. Disruption of these rhythms can have profound influences on our health (9, (11) (12) (13) . Endometrial carcinoma (EC) is the most common gynecological malignancy in many parts of the world (14) (15) (16) . Studies have shown that the molecular mechanism of carcinogenesis of the endometrium involves several pathways. These pathways include the activation of oncogenes, inactivation of tumor suppressor genes, defects in the DNA-mismatch repair genes and other tumor-related genes involving apoptosis, proteolysis, adhesion and angiogenesis (17) (18) (19) (20) (21) .
Studies of animal models and human tumor samples have revealed that the disruption of circadian rhythms is an important endogenous factor that contributes to mammalian cancer development (13) . In this study, we developed a realtime quantitative RT-PCR method to analyze the mRNA expression levels of the nine circadian genes in endometrial cancers and their paired non-tumor tissues to explore the possible role of these genes in the development of endometrial cancer.
Materials and methods

Samples.
Resected primary endometrial carcinomas (EC) and their paired non-cancerous tissue samples (including nontumorous endometrial glands, endometrial stroma, and small amounts of myometrium), all of which were histologically confirmed, were obtained from 35 patients at the Changhua Christian Hospital from October 1998 to October 2003. The Table I . RT-PCR primer and probe for circadian genes. 
tissues were frozen immediately after surgical resection and stored in liquid nitrogen until extraction of either DNA or RNA. DNA extraction was performed as previously described (22) . Total RNA was extracted by a commercial kit (RNA-Bee™; Tel-Test Inc., TX, USA), and stored either as RNA pellets in ethanol or solubilized in RNase-free water and kept at -70˚C. Of the cancerous samples analyzed in this study, 2 were clinically diagnosed as stage IB, 5 were stage IC, 4 were stage IVB, 3 were stage IIA, 3 were stage IV, 2 stage IA, 2 were stage IIIC, and 1 each of stage I and stage II. All cancerous tissue samples were endometrioid adenocarcinoma with 13 cases taken from atrophic endometrium, 12 cases from atypical hyperplastic endometrium, 6 cases from simple hyperplastic endometrium, and 4 cases from complex hyperplastic endometrium. The age of the patients ranged from 31 to 67 years with a mean of 52 years. This study was approved by the Institute Review Board (IRB) of the China Medical University Hospital and Changhua Christian Hospital.
Real-time quantitative RT-PCR analysis. mRNA sequences of the circadian genes were used in the design of specific forward and reverse primers and TaqMan probes with the aid of Primer Express software (Applied Biosystems, Foster City, CA). The probes were synthesized and labeled with appropriate fluorescent dyes (Applied Biosystems). Sequences of the forward and reverse primers and the probes of the nine circadian genes are shown in Table I .
For internal control of the real-time quantitative RT-PCR (qRT-PCR), expression of the glyceraldehydes-3-phosphate dehydrogenase (GAPDH) gene was included in each qRT-PCR experiment. The amount of each circadian gene mRNA was normalized to the endogenous reference GAPDH level to obtain the relative threshold cycle (¢C t ), then related to the ¢Ct of its paired non-cancerous tissue to obtain the relative expression level (2-¢¢C t) of the relative expression level of each circadian gene.
All qRT-PCR experiments were performed in an ABI-7700 sequence detector (Applied Biosystems) using a TaqMan EZ RT-PCR Core kit (Applied Biosystems) according to the manufacturer's protocol. qRT-PCR was carried out in a 25 μl final volume containing 400 nM of each primer, 200 nM probe, 300 μM of each deoxynucleotide triphosphate (dNTP), 3.0 mM manganese acetate, 2.5 U rTth DNA polymerase, and 1X PCR buffer. The RT-PCR cycling parameters were: the RT reaction was carried out at 50˚C for 2 min, and 60˚C for 30 min, followed by incubation at 95˚C for 5 min and 40 cycles of PCR reaction at 94˚C for 20 sec and 62˚C for 1 min.
To determine the accuracy of the assay, 4 replicates of each sample of total RNA were performed in 4 independent experiments. Within-run accuracy was determined by calculating the mean, standard deviation (SD), and coefficient of variance (CV) of the Ct values for each sample and each set of primers and probes used in each independent experiment.
Analyses of expression of four important circadian proteins by immunohistochemistry.
Paraffin-embedded EC tissue sections (4 μm) on poly-L-lysine-coated slides were deparaffinized. After treatment with 3% H 2 O 2 in methanol, the sections were hydrated with gradient alcohol and PBS, incubated with 10 mM citrate buffer and heated at 100˚C for 20 min in PBS. After incubation with the goat polyclonal antibodies for PER1, PER2, PER3 and CK1Â (Santa Cruz Biotechnology, CA, USA) for 20 min at room temperature (1:75 dilution of the concentration used in each case), the sections were incubated with an HRP/Fab polymer conjugate for another 30 min after being thoroughly washed 3 times with PBS. The sites of peroxidase activity were visualized using 3, 3'-diamino-benzidine tetrahydrochloride as substrates. Hematoxylin was used as the counterstain. Appropriate positive and negative controls were also included.
Statistics analysis.
Comparison between relative expression levels of the circadian genes in tumorous and non-tumorous tissues was analyzed using a t-test run on SPSS for Windows, release 9.0 (SPSS, Chicago, IL).
Results
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was performed in 35 paired endometrial cancer (EC) samples. TaqMan real-time RT-PCR technology was used to obtain the quantitative gene expression profiles normalized using the endogenous GAPDH mRNA level. The normalized circadian gene RNA level (¢Ct) of a cancerous tissue was then compared with the ¢Ct of the paired non-cancerous tissue of the same EC patient to determine the relative expression levels between the cancerous and non-cancerous parts. The results show that the RNA levels of PER1 and CK1Â were significantly decreased compared with those in the paired non-cancerous tissues (Table II) . Comparing expression of the nine circadian genes case by case, we found greater differences than the statistical analysis. Of the 35 cancerous tissues, 13 showed reduced expression in all nine circadian genes analyzed, reduction in eight genes was found in 7 cases, reduction in seven genes was detected in 5 cases, reduction in five genes was found in 2 cases, and there was a single case that had four circadian genes reduced in expression, in comparison with their paired non-cancerous tissues. On the other hand, there were 3 cases with all nine circadian genes, 1 case with eight genes, 2 cases with seven genes and 1 case with six genes with reduced expression in the noncancerous tissues in comparison with the paired cancerous tissues. There was no clear relationship between pathological grade, clinical stage and expression levels of the circadian genes. These qRT-PCR results indicate that the expression of 4 of the 9 circadian genes tested, namely PER1-3 and CK1Â, differs significantly between the cancerous and paired noncancerous cells in EC. Differences in expression of these circadian genes may result in the operation of different circadian clocks between cancerous cells and their nearby non-cancerous cells.
Immunohistochemistry analyses of PER1, PER2, PER3 and CK1Â. Because the period genes (PERs) occupy a strategic position in the current model of circadian rhythms and a significant decrease in expression of the CK1Â gene in cancerous tissues was observed, we next examined whether the levels of the PER1, PER2, PER3 and CK1Â proteins in the 35 paired EC and non-cancerous tissues were also affected using immunohistochemical staining. The results showed three different protein profiles: type 1 (12 cases) showed synchronized expression of all four proteins between cancerous and their paired non-cancerous cells (Fig. 1A) ; type 2 (5 cases) showed asynchronized expression of all four proteins between cancerous and their paired non-cancerous cells (Fig. 1E) ; and type 3 (18 cases) showed differential expression of one, two or three proteins between cancerous and their paired non-cancerous cells (Fig. 1B-D) . From these results, we found that expression levels of the three PER and CK1Â proteins are perturbed in EC in most cases analyzed. Perturbed PER protein expression levels in cancerous cells may have led to a different circadian rhythm from the paired noncancerous cells. On the other hand, the cancerous tissue of the same patient in the type 2 and type 3 protein profiles showed different staining patterns of the four circadian proteins in cancerous cells; some cells were strongly stained, and some were weak or negatively stained. From these results, we suggest that type 2 and 3 cancerous tissues may contain cancerous cells with different circadian rhythms in the same tissue, consistent with the existence of a heterogeneous cancer cell population within cancerous tissue.
Discussion
We have developed a real-time quantitative RT-PCR protocol to analyze the expression of nine circadian genes in 35 endometrial carcinoma samples. Despite the observation that only PER1 and CK1Â showed statistically significant differences, our results show different gene expression patterns in the cancerous cells in all EC cases examined in comparison with their paired nearby non-cancerous cells. These results suggest that the circadian rhythms in cancer cells of EC are different from their paired non-cancerous cells. Furthermore, we also found different gene expression patterns within the cancer cell population of the same cancer tissue, which suggests the concurrent existence of multiple asynchronized circadian rhythms in the same cancer tissue and indicates cancer cell heterogeneity in EC. Our results may provide a molecular basis for the development of a chronotherapeutical strategy for EC treatment based on differences in the circadian rhythms between cancerous and non-cancerous cells with the aim of achieving different drug sensitivities and effects (23) (24) (25) (26) (27) (28) .
PER1 and CK1Â proteins play an important role in the circadian clock (1-7). Homozygous mPer1 mutant displayed a shorter circadian period with reduced precision and stability (29) . CK1Â phosphorylates the PER proteins, and renders the CRY-unbound phosphorylated PER proteins unstable and degraded by ubiquitylation. The CRY-bound stable CK1Â/PER/CRY complexes enter the nucleus to disrupt the CLOCK/BMAL1-associated transcriptional complex, resulting in inhibition of the transcription of CRY, PER, REV-ERB· genes and derepression of BMAL1 transcription (1-7). These events produce a high level of BMAL1 and the beginning of a new circadian day (1-7). Hence, down-regulation of the expression of PER1 and CK1Â will result in a disturbance of the expression of other circadian genes and subsequent disruption of the circadian clock. Thus, down-regulating PER1 and CK1Â results in the dysregulation of control of the central pacemaker in EC cells.
Circadian rhythms of peripheral tissues are regulated by the central pacemaker through hormones and neuronal factors via various signaling pathways (30) (31) (32) (33) . A previous study has shown that the circadian rhythm controls the expression of cell cycle-related genes, and the intracellular circadian clockwork controls the cell-division cycle directly and unidirectionally in proliferating cells (34) . Based on these observations, we suggest that differences in the circadian rhythm in EC cancer cells may result in disrupting regulation of the central pacemaker and cell cycle-related genes, events that may favor proliferation of the cancerous cells of EC.
TaqMan real-time RT-PCR is an exact method for quantitative measurement of mRNA levels with high sensitivity, specificity and reproducibility. It is also a method of choice for surveying mRNA expression levels of multiple members in gene families. In this study, we applied this methodology to determine the circadian gene expression profiles of endometrial cancers; the obtained data were supplemented and supported by data derived in immunohistochemical staining of the same tissue set.
